United States · 
Who invested in Rectify Pharmaceuticals?
Rectify Pharmaceuticals's investors include Atlas Venture, Forbion Capital Partners, Omega Funds and Longwood Fund.
United States · Series A startup
Who invested in Rectify Pharmaceuticals
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $100MOct 2021
- Investors
- 4
The rounds
- Oct 2021
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Rectify Pharmaceuticals
How much has Rectify Pharmaceuticals raised?
Rectify Pharmaceuticals has raised $100M across 1 round since 2021.
When did Rectify Pharmaceuticals last raise?
Rectify Pharmaceuticals's most recent round was a Series A of $100M in Oct 2021.
What was Rectify Pharmaceuticals's biggest round?
Its most recent round, $100M in Oct 2021, is also its largest on record.
Who backed Rectify Pharmaceuticals first?
Rectify Pharmaceuticals's first round on record, in Oct 2021, was backed by Atlas Venture, Forbion Capital Partners and Omega Funds and 1 others.
What stage is Rectify Pharmaceuticals at?
Rectify Pharmaceuticals's latest named round is a Series A, in Oct 2021.
Where is Rectify Pharmaceuticals based?
Rectify Pharmaceuticals is based in the United States.
Companies like Rectify Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.